Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

2016 ASCO Annual Meeting /
Radiotherapy modalities for locally advanced non-small cell lung cancer

3rd - 7th Jun 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.06.16
Views: 1908

Dr Zhongxing Liao - University of Texas MD Anderson Cancer Center, Houston, USA

Dr Liao talks to ecancertv at ASCO 2016 about the results of a Bayesian randomised trial comparing intensity modulated radiation therapy versus passively scattered proton therapy for locally advanced non-small cell lung cancer.

Of the 255 patients selected, Dr Liao reports that the occurence of treatment failure (TF), defined as either local recurrence or grade ≥ 3 radiation pneumonitis (RP), was no different between those receiving intensity-modulated radiotherapy (IMRT) or 3D proton therapy, (3DPT)  but hightlights that 3DPT offers more targeted dosing, and could spare damage to surrounding tissues.

For more on proton therapy, you can watch an interview with Dr Madhusmita Behara here.

ecancer's filming at ASCO 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation